In this report, we evaluated PD-L1 and PDL-2 expression in human IBD colonic mucosa and tested the hypothesis that changes in PD-1 ligand-mediated CMF signaling contributes to the dysregulation of Th1/Th2 cell responses in human IBD. The gene discussed is PDCD1LG2; the disease is inflammatory bowel disease.